Can integrase inhibitors reduce mortality?
- PMID: 35659330
- DOI: 10.1016/S2352-3018(22)00103-5
Can integrase inhibitors reduce mortality?
Conflict of interest statement
MBK reports research support from ViiV Healthcare, AbbVie, and Gilead Sciences and consulting fees from ViiV Healthcare, AbbVie, and Gilead Sciences all outside the submitted work. MBK is supported by a Tier I Canada Research Chair. JY declares no competing interests.
Comment on
-
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study.Lancet HIV. 2022 Jun;9(6):e404-e413. doi: 10.1016/S2352-3018(22)00046-7. Lancet HIV. 2022. PMID: 35659335 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical